Show simple item record

P570 Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN

dc.contributor.authorWeintraub, Yen_US
dc.contributor.authorVeit, LCen_US
dc.contributor.authorHussey, Sen_US
dc.contributor.authorMitrova, Ken_US
dc.contributor.authorCroft, NMen_US
dc.contributor.authorKang, Ben_US
dc.contributor.authorGranot, Men_US
dc.contributor.authorD'Arcangelo, Gen_US
dc.contributor.authorSpencer, Een_US
dc.contributor.authorKolho, KLen_US
dc.contributor.authorYeh, PJen_US
dc.contributor.authorSladek, Men_US
dc.contributor.authorScarallo, Len_US
dc.contributor.authorPérez, LPen_US
dc.contributor.authorAfzal, Nen_US
dc.contributor.authorde Laffolie, Jen_US
dc.contributor.authorMiele, Een_US
dc.contributor.authorBramuzzo, Men_US
dc.contributor.authorOlén, Oen_US
dc.contributor.authorRussell, Ren_US
dc.contributor.authorRohani, Pen_US
dc.contributor.authorTzivinikos, Cen_US
dc.contributor.authorUrlep, Den_US
dc.contributor.authorvan Rheenen, Pen_US
dc.contributor.authorde Ridder, Len_US
dc.contributor.authorYogev, Den_US
dc.contributor.authorSchneider, AMen_US
dc.contributor.authorCohen, Sen_US
dc.contributor.authorRomero, RGen_US
dc.contributor.authorDipasquale, Ven_US
dc.contributor.authorUhlig, Hen_US
dc.contributor.authorS., DSen_US
dc.date.accessioned2024-07-31T11:34:38Z
dc.date.issued2024-01-24en_US
dc.identifier.issn1197-4982en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/98501
dc.format.extenti1114 - i1115en_US
dc.publisherOxford University Press (OUP)en_US
dc.relation.ispartofJournal of Crohn's and Colitisen_US
dc.subjectDigestive Diseasesen_US
dc.subjectClinical Researchen_US
dc.subjectInflammatory Bowel Diseaseen_US
dc.subjectClinical Trials and Supportive Activitiesen_US
dc.subjectAutoimmune Diseaseen_US
dc.subjectPediatricen_US
dc.subjectCrohn's Diseaseen_US
dc.subject5.1 Pharmaceuticalsen_US
dc.subject6.1 Pharmaceuticalsen_US
dc.subjectOral and gastrointestinalen_US
dc.titleP570 Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHANen_US
dc.typeArticle
dc.identifier.doi10.1093/ecco-jcc/jjad212.0700en_US
pubs.issueSupplement_1en_US
pubs.notesNot knownen_US
pubs.volume18en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record